Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 27 Jul 2026 for Immunome Inc..
Filing timeline
BuySaleMax Rosett
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Max Rosett: trading record in brief
All filings by Max Rosett on record concern Immunome Inc. Over a trading history stretching from 19 September 2024 to 23 July 2026, the count stands at 7 filings.
The open-market record consists of 3 sales worth €1.4M, with no purchase. The rest of the record consists of 1 share grant and 3 option exercises. 2026 to date brings no purchases and 2 sales.
The latest filing, published on 27 July 2026, reports a share grant in Immunome Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Max Rosett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
47,250 shares0Common StockSEC:0001994071-26-000006:0
31,848 shares@ US$1.052.1% of flowCommon StockSEC:0001994071-26-000002:0
39,713 shares@ US$1.353.4% of flowCommon StockSEC:0001994071-26-000002:1
63,656 shares@ US$21.9189.5% of flowCommon StockSEC:0001994071-26-000002:2
1,344 shares@ US$22.481.9% of flowCommon StockSEC:0001994071-26-000002:3
42,000 shares@ US$1.05100.0% of flowCommon StockSEC:0001415889-24-023809:0
6 of 6 declarations
